Restrictive access to interferon- -1b criticised in France

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.260, 2000-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

UK criticised over access to new cancer drugs

Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Interferon--1a/interferon--1b: Polyneuropathy: 6 case reports

Reactions Weekly, Vol. 1, Iss. 1081, 2005-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite

Interferon-β_1b for the treatment of multiple sclerosis

By Lam Sum Wang Shan Gottesman Malcolm

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite

Interferon--1b: Mononeuropathy: case report

Reactions Weekly, Vol. 1, Iss. 1121, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Interferon- -1b reimbursable for MS patients in Canada

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 247, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite